1. Home
  2. UTI vs GLPG Comparison

UTI vs GLPG Comparison

Compare UTI & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Technical Institute Inc

UTI

Universal Technical Institute Inc

HOLD

Current Price

$35.74

Market Cap

2.0B

Sector

Real Estate

ML Signal

HOLD

Logo Galapagos NV

GLPG

Galapagos NV

HOLD

Current Price

$28.39

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UTI
GLPG
Founded
1965
1999
Country
United States
Belgium
Employees
N/A
452
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
2003
N/A

Fundamental Metrics

Financial Performance
Metric
UTI
GLPG
Price
$35.74
$28.39
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
$37.50
$36.50
AVG Volume (30 Days)
456.9K
141.7K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
50.67
N/A
EPS
0.23
N/A
Revenue
$835,616,000.00
N/A
Revenue This Year
$10.15
N/A
Revenue Next Year
$8.32
N/A
P/E Ratio
$156.83
N/A
Revenue Growth
14.05
N/A
52 Week Low
$21.29
$24.74
52 Week High
$40.41
$37.78

Technical Indicators

Market Signals
Indicator
UTI
GLPG
Relative Strength Index (RSI) 47.77 36.79
Support Level $34.49 $27.98
Resistance Level $38.16 $34.04
Average True Range (ATR) 1.35 0.47
MACD -0.20 0.10
Stochastic Oscillator 27.86 34.47

Price Performance

Historical Comparison
UTI
GLPG

About UTI Universal Technical Institute Inc

Universal Technical Institute Inc is an educational institution. It provides undergraduate degree, as well as certificate programs for technicians in the automotive, diesel, collision repair, motorcycle and marine fields. The company's reportable segment which includes Universal Technical Institute (UTI) and Concorde Career Colleges, Corporate. Majority of the revenue is generated from UTI segment which provides different kinds of degree and non-degree transportation and skilled trades technical training programs under brands such as Universal Technical Institute, Motorcycle Mechanics Institute, Marine Mechanics Institute and others. It also provides dealer technician training or instructor staffing services to manufacturers.

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, and it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.

Share on Social Networks: